GlaxoSmithkline Consumer Healthcare rose 2.12% to Rs 2,695 at 15:03 IST on BSE after net profit jumped 29.27% to Rs 106.60 crore on 14.15% growth in total income to Rs 786.96 crore in Q2 June 2012 over Q2 June 2011.
The company announced the results during trading hours today, 1 August 2012.
Meanwhile, the BSE Sensex was up 32.33 points or 0.19% to 17,268.51.
On BSE, 3,499 shares were traded in the counter as against average daily volume of 2,898 shares in the past two weeks.
The stock hit a high of Rs 2,715 and a low of Rs 2,641 so far during the day.
GlaxoSmithkline Consumer Healthcare is leading player in the malted food drinks segment. Some of its major brands include Horlicks, Boost, Viva, and Maltova.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app